NRG GU007-Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (with Initial Phase I)

January 06, 2020
https://clinicaltrials.gov/ct2/show/NCT04037254
Cancer - Prostate
Prostate cancer, high risk prostate cancer
Accepting Participants
313-916-8862